Lupin has bolstered its diabetes and obesity portfolios by securing an agreement for Bofanglutide, a GLP-1 receptor agonist developed by Gan & Lee Pharmaceuticals
These observations are procedural in nature and the company does not anticipate any impact on supply of its commercial products
Biocon will be responsible for supplying Semaglutide to Ajanta for exclusive marketing in 23 countries and semi-exclusive marketing in 3 countries across Africa, Middle East and Central Asia
The said certificate is valid for a period of 3 years and opens up the European and other markets for the company's products
The product will be marketed by Dr. Reddy's Laboratories Inc.
The agreement pairs Croda’s global footprint and “smart science” approach with Amino’s precision manufacturing capabilities
DUPLEX’s two-compartment, PVC- and DEHP-free design keeps medication and diluent separate until activation
VitiPure serves as essential solubilizers, emulsifiers, and bioavailability enhancers in drug formulations
Sun Pharma to set up Rs. 3,000 crore greenfield formulations facility in MP
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
